Pixium Vision News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.02.22	Pixium Vision announces its unaudited financial results for 2021 and provides a business update (GlobeNewswire)
27.01.22	Pixium Vision announces the publication in Nature Communications of peer-reviewed clinical data demonstrating the clinical benefit of the Prima System in Dry AMD patients (GlobeNewswire)
06.01.22	Pixium Vision to attend BIOMED EVENT® by Invest Securities on January 26, 2022 (GlobeNewswire)
14.12.21	Pixium Vision to attend 11th Annual LifeSci Partners Corporate Access Event (GlobeNewswire)
08.12.21	Pixium Vision gaining confidence in execution timeline of the PRIMAvera pivotal trial following first patient implantation in the UK (GlobeNewswire)
25.11.21	Pixium Vision to present at BTIG’s Ophthalmology Day (GlobeNewswire)
08.11.21	Pixium Vision to present at the 3rd edition of Investir Day in Paris, November 2021 (GlobeNewswire)
22.10.21	Pixium Vision announces its cash position at 30 September 2021 and provides an update on its activities and financial outlook until the end of 2022 (GlobeNewswire)
13.10.21	Pixium Vision announces positive long-term follow-up scientific data on PRIMA implant from Prima System French feasibility study (GlobeNewswire)
02.06.21	Pixium Vision announces business update and key upcoming milestones to deliver on its business plan (GlobeNewswire)
10.05.21	General Meeting of 27 May 2021 Procedures for participating (GlobeNewswire)
21.04.21	Pixium Vision receives HealthTech Award for Prima System at the MedTech Forum (GlobeNewswire)
19.04.21	Pixium Vision announces the drawdown of a further tranche, with a nominal value of €1.5 million, under the financing contract with ESGO (GlobeNewswire)
18.04.21	Pixium Vision announces its cash position at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021. (GlobeNewswire)
07.04.21	Pixium Vision announces first patient successful implantation in Prima System pivotal trial PRIMAvera (GlobeNewswire)
03.04.21	Termination of the business combination with Second Sight Medical Products, Inc. (GlobeNewswire)
09.03.21	Continuation of the business combination project between Pixium Vision et Second Sight Medical Products (GlobeNewswire)
19.02.21	Pixium Vision announces its financial results for 2020 and provides a business update (GlobeNewswire)
06.01.21	Pixium Vision and Second Sight Medical Products announce business combination, creating a global leader in the sight restoration market (GlobeNewswire)
20.11.20	Pixium Vision receives French regulatory authority (ANSM) approval to initiate European PRIMAvera pivotal study of Prima System (GlobeNewswire)
22.10.20	Pixium Vision announces its cash position at 30 September 2020 (GlobeNewswire)
16.10.20	Pixium Vision Hosting Key Opinion Leader Webinar on the Prima System for Atrophic Dry Age-related Macular Degeneration (dry-AMD) (GlobeNewswire)
27.04.18	Pixium Vision’s Research Partner, Stanford University, to Present Advances on Bioelectronic PRIMA Platform Technology During ARVO 2018 (Businesswire)
25.01.18	Pixium Vision Completes World’s First Successful Activation in Human of PRIMA Bionic Vision System (Businesswire)
04.01.18	Pixium Vision receives FDA approval to begin human clinical study of its PRIMA sub-retinal implant in the US (Businesswire)
19.10.17	Pixium Vision Receives Approval for First-in-Human Clinical Trial of PRIMA, Its Miniaturized Sub-Retinal Implant (Businesswire)
22.11.16	Pixium Vision and Silamir, Honoured at Quai d’Orsay, during the Award Ceremony of Janus 2016 from French Institute of Design (Businesswire)
07.11.16	Pixium Vision Announces the First Successful Implantation and Activation of IRIS® II, 150 Electrode Bionic Vision System, in the UK (Businesswire)
27.10.16	Pixium Vision: Results for the First 9 Months of 2016 (Businesswire)
29.09.16	Pixium Vision announces an 11 million Euros bond financing facility (Businesswire)
12.09.16	Pixium Vision Receives Clinical Trial Approval from Spanish Ministry of Health for 150 Electrode Iris®II Bionic Vision System (Businesswire)
25.07.16	Pixium Vision announces CE market approval of IRIS®II, its first bionic vision system (Businesswire)
20.07.16	Pixium Vision First Half 2016 Financial Results and Business Update (Businesswire)
31.05.16	Pixium Vision Receives Clinical Trial Approval From UK Regulatory Authority for 150 Electrode IRIS®II Bionic Vision System (Businesswire)
31.05.16	Pixium Vision Receives Clinical Trial Approval from UK Regulatory Authority for 150 Electrode IRIS®II Bionic Vision System (Businesswire)
04.05.16	Pixium Vision and Research Partners Report Significant Progress on PRIMA, a Tiny Wireless Sub-Retinal Implant During ARVO - World's Largest Vision Research Annual Conference (Businesswire)
27.04.16	Pixium Vision Announces Its First Quarter 2016 Financial Update and a New Date for Its Annual General Meeting (Businesswire)
24.02.16	World Premiere: Pixium Vision Implants IRIS® II, First Epi-Retinal Implant with 150 Electrodes (Businesswire)
24.02.16	World Premiere: Pixium Vision Implants IRIS® II, First Epi-Retinal Implant with 150 Electrodes (Businesswire)
16.02.16	Pixium Vision Receives Approval from German Regulatory Authority to Implant 150 Electrode IRIS® II in Clinical Trial (Businesswire)
29.01.16	Pixium Vision 2015 Financial Results and Business Update (Businesswire)
20.01.16	Pixium Vision’s 2016 Financial Calendar (Businesswire)
07.01.16	Pixium Vision Announces Positive Preclinical Safety and Feasibility Data for PRIMA, a Tiny, Wireless Subretinal Implant (Businesswire)
04.01.16	Full Year Update on Pixium Vision’s Liquidity Agreement (Businesswire)
21.12.15	Pixium Vision files for CE Mark for IRIS®II, its first Vision Restoration System (Businesswire)
14.12.15	Pixium Vision Receives Approval from French Regulatory Authority to Implant IRIS® II in Clinical Study (Businesswire)
11.12.15	Pixium Vision Receives the 2016 Observeur Du Design Award for IRIS®, Its First Vision Restoration System (Businesswire)
29.10.15	Pixium Vision: Sales for the First 9 Months of 2015 (Businesswire)
28.10.15	Pixium Vision wins the 2015 Janus Healthcare prize from prestigious French Institute of Design (Businesswire)
21.10.15	Pixium Vision Implants Additional Patients in the European Clinical Trial of Its Epi-Retinal System IRIS® (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	4’059.00	2.92 %	K V
Logitech Intl	94.36	2.03 %	K V
Part Grp Hldg	1’422.50	1.07 %	K V
Sika	242.10	0.71 %	K V
Holcim	98.62	0.39 %	K V
Roche Hldg G	294.50	-1.11 %	K V
Kuehne+Nagel Int	209.20	-1.13 %	K V
Nestle	82.48	-1.43 %	K V
Swisscom	499.80	-2.00 %	K V
Novartis	95.37	-2.46 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Pixium Vision SA

Aktien Top/Flop

Meistgelesene Nachrichten